Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.

Cihan AtilaClara Odilia SailerStefano BassettiSarah Tschudin-SutterRoland BingisserMartin SiegemundStefan OsswaldKatharina RentschMarco RueeggSabrina SchaerliGabriela M KusterRaphael TwerenboldMirjam Christ-Crain

Published in: European journal of endocrinology (2021)

Our results underline the importance of dysnatremia as predictive marker in COVID-19. Treating physicians should be aware of appropriate treatment measures to be taken for patients with COVID-19 and dysnatremia.

Keyphrases

coronavirus disease
sars cov
primary care
risk factors